Trial Details
RECRUITINGBasic Information
| Clinical ID | c2146 |
|---|---|
| Identifier | NCT03917303 |
| Trial Title | Control Crohn Safe Trial |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Inflammatory Bowel Diseases |
| Interventions | DRUG: Adalimumab|DRUG: standard step-up care |
Participant Information
| Sponsor | Maastricht University Medical Center |
|---|---|
| City | Maastricht |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2019-12-23 |
|---|---|
| Primary Completion Date | 2024-05 |
| Completion Date | 2026-09 |